# PREDICT Cytomegalovirus (CMV)

> **NCT03300882** · — · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 84 (actual)

## Conditions studied

- Lung Transplant

## Interventions

- **OTHER:** Procedure

## Key facts

- **NCT ID:** NCT03300882
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-31
- **Primary completion:** 2019-11-25
- **Final completion:** 2019-11-25
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2020-08-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03300882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03300882, "PREDICT Cytomegalovirus (CMV)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03300882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*